Introduction
Thiazole, pyrimidine and related pyrimidines are classes of fused heterocycles that are of considerable interest because of the diverse range of their biological properties. These are among a wide variety of nitrogen heterocycles that have been explored for developing pharmaceutically important molecules. Thiazolopyrimidine and related fused heterocycles are of interest as potential bioactive molecules, which can be considered as thia-analogues of the natural purine bases such as adenine and guanine, and have acquired a growing importance in the field of medicinal chemistry because of their biological potential. They are known to exhibit pharmacological activities such as analgesic, antiinflammatory, antiarrhythmic, antiparkinsonian, and anticancer activities (1) (2) (3) (4) (5) (6) (7) (8) .
Cancer is a collection of different life threatening diseases characterized by uncontrolled growth of cells leading to invasion of surrounding tissue and often spreading to other parts of the body. When it comes to understanding and controlling cancer scientists are now working from a position of strength because a foundation of knowledge about cancer has been built over the past 50 years. There is an urgent need for novel effective drug regimens for the treatment of cancer because the current chemotherapy suffers from a slim therapeutic index, with significant toxicity from effective drug doses or tumor recurrence at low drug doses. The new anticancer chemotherapeutic agents search continues to be an active area of research at many companies and research centers (9, 10) . Searching for new anticancer agents having heterocyclic nucleus continues worldwide at various laboratories (11) (12) (13) .
In the last several decades, fused pyrimidine derivatives are a class of heterocyclic compounds that have attracted signifi cant interest in medicinal chemistry because they have a wide range of pharmaceutical and pharmacological applications including potential anti-tumor, antimycobacterial, and antiviral activities. Moreover, in recent years, it was reported that many fused pyrimidine analogues were reported to be inhibitors of tyrosine kinase and cyclin-dependent kinases, which are involved in mediating the transmission of mitogenic signals and numerous other cellular events (14) (15) (16) (17) (18) (19) , including, cell proliferation, migration, differentiation, metabolism, and immune responses. It was also found that many of these derivatives may block proliferation of various cancer cell lines (20) . Led by the above facts on pyrimidine chemistry, we have synthesized new 2-(substituted benzylidene)-7-(4-fl uorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives (4a-4j). The main objective of the present investigation is a modified experimental approach to evaluate position of substitutions in synthesized compounds and validation with reference drugs such as gefi tinib. The introduction of the substituted benzylidene at the 2nd position of the thiazolopyrimidine scaffold led to signifi cant anticancer activity.
Materials and Methods

Chemicals and reagents
The chemicals and reagents used were obtained from various chemical units including Aldrich Co. (Powai, Mumbai, India), E. Merck India Ltd. (Ponda, Goa, India), CDH (Daryaganj, New Delhi, India), and SD Fine Chem (Worli Road, Mumbai, India). These solvents used were of laboratory research (LR) grade and purifi ed before their use. The silica gel G used for analytical chromatography (TLC) was obtained from E. Merck India Ltd. Melting points were measured in open capillary tubes on a Boetius apparatus (Carl Zeiss Jena) and are uncorrected. H-NMR spectra were taken on a 300 MHz NMR spectrometer (model Ultra Shield, Bruker, Rheinstetten, Germany) in (d 6 -DMSO) using tetramethylsilane [(CH 3 ) 4 Si] as internal standard. Chemical shifts (δ) are expressed in ppm. Mass spectra were obtained on an instrument (JEOL-SX-102, Japan) using electron impact ionization. IR spectra were recorded in KBr pellets on a Fourier-transform infrared spectrometer (FT-IR 410, Jasco Corporation, Tokyo, Japan). Elemental analyses were performed on an elemental analyzer (Model 240c, Perkin Elmer, Thane, Maharashtra, India) and were within ± 0.4% of the theoretical values.
General procedure for the synthesis of title compounds (4a-4j)
Preparation of 3-(4-fluorophenyl)-1-(furan-2-yl)prop-2-en-1-one (1)
The key intermediates were synthesized by a previously reported method (21) 
4-(4-Fluorophenyl)-6-(furan-2-yl)-3,4-dihydropyrimidin-2(1H)-thione (2)
A mixture of 3-(4-fluorophenyl)-1-(f uran-2-yl)prop-2-en-1-one (1) (0.039 mol) thiourea (0.03 mol) and potassium hydroxide (2.5 g) in 95% ethanol (100 mL) was heated under reflux for 3 h. The reaction mixture was concentrated to half of its volume, diluted with water, then acidifi ed with dilute acetic acid and kept overnight. 
7-( 4-F luoro phen yl )-5-( f uran-2-yl )-2H -thiazolo[3,2-a]pyrimidin-3(7H )-one (3)
The chloroacetic acid (0.096 mol) was melted on a water bath and (2) (0.009 mol) added to it portion wise to maintain its homogeneity. The homogeneous mixture was further heated on a water bath for 30 min and kept overnight. -50 mM) . The cells were later incubated for 72 h. Cytotoxicity was measured by adding 5 mg/mL of MTT to each well and incubating for another 3 h. The purple formazan crystals were dissolved by adding 100 μL of DMSO to each well. The absorbance was read at 570 nm in a spectrophotometer. Cell death was calculated as follows: Cell death percentage = 100 -[test absorbance/ control absorbance] × 100. The test result is expressed as the concentration of a test compound which inhibits the cell growth by 50% (IC 50 ).
Results and Discussion
Chemistry
The chemical structures of the synthesized compounds were confirmed by infrared spectroscopy, proton nuclear magnetic resonance spectroscopy, mass spectrometry, and elemental analysis. The presence of the carbonyl and olefi nic group in compound (1) is characterized by the presence of two strong bands in its IR spectrum at 1,733 and 1,631 cm -1 . The formations of compound (2) were confirmed by NH stretching, bending peaks in the range of 3,382, 1,621 cm -1 , and appearance of a singlet peak 3.27 for two protons in its 1 H-NMR spectra which might be assigned to NH group connecting the pyrimidine. The conversion of thiazolo[3,2-a]pyrimidin-3(7H )-one (3) can be recognized by a strong absorption peak at 1,721cm -1 in IR due to the carbonyl group in the thiazole ring. The title compounds (4a-4j) showed a singlet at δ 7.12, 7.35, 7.32, 7.31, 7.14, 7.22, 7.25, 7.23, 7.19, and 7.32 ppm due to the benzylidine ring proton in 1 H-NMR confi rms the formation of (4a-4j) respectively. Further mass spectra confi rmed their purity and molecular weight.
Biological activity
All the selected compounds 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a] pyrimidin-3(7H)-one (4a-4j) were evaluated for cytotoxic properties on the U937 human histocytic lymphoma cell line with gefitinib as a standard positive control. Inhibition of cell-proliferation was measured by MTT assay. The inhibitory potency (IC 50 ) of compounds (4a-4j) are given in Table 1 . The fact that a majority of clinically active anticancer drugs possess a nitrogen hetero atomic system with one or two phenyl rings, at least one carbonyl group in their structure and the presence of hydrogen donor/ acceptor unit is noted. In all of the pioneering experiments important core fragments (23) are defi ned by the presence of a hydrogen donor/acceptor unit (HAD), a hydrophobic domain (A) (aryl ring substituted/unsubstituted) and an electron donor atom (D). These common features were found in the structures of well-established anticancer drugs such as gefi tinib, erlotinib, lapatinib, and dasatinib as well as synthesized compounds (Figure 1 
General proced ure f or the s ynthesis o f 2-(substitutedbenzylidene)-7-(4-fl uorophenyl)-5-( furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H )-one (4a-4j)
A mixture of (3) (0.002 mol), substituted benzaldehyde (0.002 mol), and anhydrous sodium acetate (0.002 mol) in 100% glacial acetic acid (10 mL) was heated under refl ux for 4 h. The reaction mixture was kept overnight and the solid, thus separated, was fi ltered, washed with water and recrystallized from ethanol to furnish 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(f uran-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one (4a-4j) (Scheme 1).
Cell proli f eration assay
The U937 human histocytic lymphoma cell line was obtained from cell line bank of National Center for Cellular Sciences (NCCS), Pune, India. These cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37 o C, in a CO 2 incubator in the presence or absence of test compounds. The anticancer property of the compounds was measured by MTT assay (22) . The cells were plated in a 96-well plate at a density of 5,000 cells/well. After 24 h, cell culture media was replaced with DMEM containing 10% FBS and the cells were treated with different concentrations of the compounds Synthetic protocols of target compounds (4a-4j) . Comp.
lipophilicity is one of the most important parameters because it is mainly involved in pharmacokinetic processes such as absorption, distribution, metabolism, excretion, and toxicity (ADMET) and in ligand-target interactions (24) . Lipophilicity is the molecular parameter of choice in numerous quantitative structure-activity relationships (QSAR) of different classes of compounds (25) . The promising activity of the compounds may be attributed to the substitutions on the hydrophobic domain. These compounds contain methyl, hydroxy, nitro, and halogens at the para position of the benzylidene aryl ring. Moreover, observed data showed that the para substituted derivatives exhibited better activity than other ortho and unsubstituted derivatives. Compounds 4f and 4h were found to be most potent and showed IC 50 values of 3.04 and 3.51 mM, respectively. When the ortho group was on the benzylidene aryl ring of compounds, we found a decrease in inhibitory activity. For example, compounds 4d and 4i were 3-fold less potent than 4e and 4j. Among the ten compounds synthesized, we found that compounds 4f and 4h showed comparable activity to that of gefitinib. Moreover, p-CH 3 , p-OH, and p-NO 2 substituted compounds (4c, 4e, and 4j) had slighter lower activity than (4f-4h). However, the unsubstituted and ortho substituted (o-methyl, o-hydroxyl, and o-nitro) compounds (4a, 4b, 4d, and 4i) exhibited lesser activity. The anticancer activity of test compounds with decreasing order is shown in Figure 2 and is tabulated in Table 1 .
Structure activity relationships (SAR) study
SAR studies give insights into molecular properties causing receptor affinity and selectivity. The promising nature of the compounds may be attributed to the substitutions on the hydrophobic domain (benzylidene aryl ring). These compounds had electron withdrawing and donating groups at the ortho and para positions of the hydrophobic aryl ring. In general it was observed that the para substituted derivatives were more active than the other derivatives. This may be because of the fact that the para substituted derivatives fi t better into the receptor site.
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Based on these general concepts we planned to prepare different modifications in title compounds, namely, ortho and para substitution in the thiazolopyrimidine ring. These modifications showed insight into the dependency of the receptor binding efficacy. Furthermore the para substituted thiazolopyrimidine skeletal structure conserved the good receptor binding results. Finally para substituted compounds 4c, 4e, 4f, 4g, 4h, and 4j exhibited signifi cant anticancer activity.
Conclusions
The literature survey revealed that para substitution on the phenyl ring appeared to greatly influence pharmacological activity. This research examined anticancer properties of a novel series of 2-(substituted benzylidene)-7-(4-fluorophenyl)- 
